ZALIHANCE
associated with 40 other trademarks
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections...

Words that describe this trademark:

Serial Number:

97652324

Mark:

ZALIHANCE

Status:

Abandoned-No Statement of Use filed

Status Date:

06-17-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

09-19-2023

Mark Drawing Status:

4

Abandon Date:

06-17-2024

Business Name:

600 ATLANTIC AVENUE

Recent Trademark filings by this company